The role of noninvasive positive pressure ventilation (NIPPV) in adult respiratory distress syndrome (ARDS) is controversial, in contrast to its well established benefits in other types of respiratory failure, especially acute exacerbations of chronic obstructive pulmonary disease and cardiogenic pulmonary oedema. We report a case of ARDS caused by Mycoplasma pneumoniae in a 70 year old man, tr...

Purpose: To investigate the pulmonary outcomes of early extubation (within the first 24 hours of life) with synchronized nasal intermittent positive pressure ventilation (NIPPV) in extremely premature infants born at 25–26 weeks’ gestation. Methods: Medical records of extremely premature infants (gestational age: 25–26 weeks) born and admitted to the Keimyung University Dongsan Medical Center b...

Ten patients with respiratory failure and nocturnal hypoventilation were treated for three to nine months by nasal intermittent positive pressure ventilation. Four patients had chronic obstructive lung disease (median FEV1 19% predicted) and six restrictive chest wall disorders (median FVC 25% predicted); eight of the patients also had cardiac failure. The median daytime arterial oxygen tension...

Non-invasive ventilation has been used increasingly in recent years to reduce the duration of endotracheal ventilation and its complications, especially bronchopulmonary dysplasia. Nasal continuous positive airway pressure and nasal intermittent positive pressure ventilation are the most common non-invasive modalities, and nasal high-frequency oscillatory ventilation (n-HFOV) is relatively new ...

Twenty-nine patients with a neuronopathic or neuropathic disorder were referred for assessment of respiratory insufficiency between 1978 and 1994. Diagnoses included spinal muscular atrophy (6), chronic idiopathic demyelinating neuropathy (4), Vialetto-van Laere syndrome (3), hereditary motor and sensory neuropathy (3) and a miscellaneous group (5). We also describe seven patients with Guillain...

NASAL INTERMITTENT POSITIVE pressure ventilation (nIPPV) is a noninvasive modality of ventilatory support that is frequently used for a number of clinical conditions. Suggested applications for nIPPV include the treatment of respiratory distress and apnea of prematurity, sleep apnea syndromes, chronic obstructive pulmonary disease, and as a bridge between mechanical ventilation and unassisted b...

The impact of noninvasive positive-pressure ventilation (NIPPV) on pulmonary function studies, quality of life, and survival was assessed in patients with amyotrophic lateral sclerosis. NIPPV did not change the rate of decline of the forced vital capacity (FVC) and forced expiratory volume in the first second (FEV(1)) (2.31 and 2.09 percent-predicted points per month, respectively). NIPPV resul...

Acute respiratory failure (ARF)-hypoxic or hypercapnic-is a critical condition often necessitating intensive care and mechanical ventilation (invasive or non-invasive) (1). Noninvasive Positive Pressure Ventilation (NIPPV) is increasingly used for specific forms of ARF because of its considerable advantages over invasive mechanical ventilation (IMV) for these conditions. Patients receiving NIPP...

We read with interest the systematic review by Zhao et al. [1] comparing the effect of the high-flow nasal cannula (HFNC) and noninvasive positive pressure ventilation (NIPPV) therapies in acute respiratory failure. Coincidentally, a similar review [2] was also published in Chest recently in which the cohort studies were also included. Both of these two reviews reported that, compared to HFNC, ...